Our manuscript is the first proof-of-concept study to utilize gain-of-function CXCR4 to enhance bone marrow homing of primary human NK cells and will set the stage for a new line of research focusing on directing adoptively infused immune cells to the cancer. This evidence concerns the gene CXCR4 and cancer.